Oventus Medical Ltd has been notified by the Pricing, Analysis and Coding (PDAC) contractors which support The Centers for Medicare & Medicaid Services (CMS) that O2Vent Optima, a customized 3D-printed nylon oral appliance, has been approved for Medicare reimbursement. This is a significant milestone that will further support the rollout of the O2Vent Optima. Dentists can now bill and be reimbursed not only by Medicare but other commercial payers that follow CMS policy.
Oventus CEO, Dr Chris Hart commented, “This is a very significant development for Oventus. It means that patients accessing government-funded healthcare in the US can now access our treatment which has been proven to have exceptional efficacy, both in our clinical trials and when used by patients for the treatment of their Obstructive Sleep Apnea. It opens up a whole market that may not have previously been able to afford our treatment and we expect further increased demand for our ‘lab in lab’ model as a result.”
Source: Oventus Medical